News Feature Channel: Cancer

How ecDNA Fuels Cancer by Breaking the Laws of Biology

Howard Hughes Medical Institute (HHMI) — Fri, 15 Nov 2024 16:15:01 EST

How ecDNA Fuels Cancer by Breaking the Laws of Biology

New Research Sheds Light on a Surprising Connection Between COVID-19 and Cancer Regression

Northwestern Medicine — Fri, 15 Nov 2024 12:00:00 EST

New research sheds light on a surprising connection between COVID-19 and cancer regression

November Research Tip Sheet

Cedars-Sinai — Fri, 15 Nov 2024 11:10:48 EST

Cedars-Sinai has published a summary highlighting its research advances for November 2024.

International Cancer Organizations Present Collaborative Work During Oncology Event in China

National Comprehensive Cancer Network(r) (NCCN(r)) — Fri, 15 Nov 2024 09:05:07 EST

The National Comprehensive Cancer Network (NCCN) is honored to participate in 2024 CCHIO. NCCN has taken numerous strides in recent years to increase the global accessibility and relevance of NCCN Guidelines as a tool for helping people with cancer to live better lives, including multiple collaborations with leading oncology groups in China.

Neuro-Oncology Experts Reveal How to Use AI to Improve Brain Cancer Diagnosis, Monitoring, Treatment

Indiana University — Thu, 14 Nov 2024 14:40:21 EST

An international team of neuro-oncology researchers and clinicians has released new recommendations for good clinical practice regarding the use of artificial intelligence methods to more accurately diagnose, monitor and treat brain cancer.

Argonne to Explore Novel Ways to Fight Cancer and Transform Vaccine Discovery with Over $21 Million From ARPA-H

Argonne National Laboratory — Thu, 14 Nov 2024 14:35:19 EST

Argonne has received up to $21 million from ARPA-H to use AI and supercomputing in two projects: one targeting hard-to-treat tumors, and another aiming to create vaccines for multiple viral threats, including cancer and pandemics.

Personalized Breast Cancer Treatment through Non-Invasive Liquid Biopsy

Sbarro Health Research Organization (SHRO) — Thu, 14 Nov 2024 13:35:22 EST

In patients with human epidermal growth factor receptor 2 (HER2)-low breast cancer, the molecular classification of their case plays a pivotal role in the formulation of personalized treatment plans aimed at optimizing outcomes. Despite notable advancements in this field, significant challenges persist. Issues such as pre-analytical variability, interpretative ambiguity, and inconsistent threshold definitions hinder accurate diagnosis and subsequent treatment decisions. In this context, emerging liquid biopsy technologies present a promising solution.

Research Concentrates on Genes That Cause Tumors in the Meibomian Gland

Tufts University — Thu, 14 Nov 2024 13:30:56 EST

Tufts University researcher dedicated to finding treatments for cancer by researching tumors that develop in Meibomian glands, the specialized oil-secreting glands of the eyelid.

University of Chicago Medicine Comprehensive Cancer Center partners with Argonne National Laboratory to accelerate the discovery of new cancer therapies using AI

University of Chicago Medical Center — Thu, 14 Nov 2024 13:05:26 EST

Researchers at the UChicago Medicine Comprehensive Cancer Center and Argonne National Laboratory are partnering to use AI approaches to discover new targets for cancer therapies

Snuff Out Teen Smoking: Johns Hopkins Children's Center Expert Available for Interviews

Johns Hopkins Medicine — Thu, 14 Nov 2024 11:00:04 EST

More than 10% of high school students in the U.S. smoke or use other tobacco products -- with most using e-cigarettes, according to the U.S. Food and Drug Administration's National Youth Tobacco Survey.

Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers

Johns Hopkins Medicine — Thu, 14 Nov 2024 10:00:23 EST

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University.

Vaccine Shows Promise Against Aggressive Breast Cancer

Washington University in St. Louis — Wed, 13 Nov 2024 20:00:00 EST

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St. Louis with a therapy designed by WashU Medicine researchers, the trial is the first to report results for this type of vaccine -- known as a neoantigen DNA vaccine -- for breast cancer patients.

Treatment Advances, Predictive Biomarkers Stand to Improve Bladder Cancer Care

University of North Carolina Health Care System — Wed, 13 Nov 2024 17:00:00 EST

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a New England Journal of Medicine editorial published by Matthew Milowsky, MD, FASCO, a bladder cancer expert at UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center.

Sylvester Cancer Tip Sheet: Researchers Present Posters at the 66th ASH Annual Meeting & Exposition

Sylvester Comprehensive Cancer Center — Wed, 13 Nov 2024 15:10:03 EST

Hematology researchers from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University of Miami are authors or co-authors on more than 70 posters to be presented at the Annual Meeting & Exposition of the American Society of Hematology in San Diego, Dec. 7-10. Links to each abstract are included in this tip sheet.

"We Need Everyone": New Award Recognizes the Importance of Scientific Community

University of Utah Health — Wed, 13 Nov 2024 13:30:03 EST

In the lab of Minna Roh-Johnson, PhD, great science and great mentorship are inextricable. Now, up to $250,000 in federal funding from the National Cancer Institute has made that philosophy concrete by advancing cancer research and building scientific community.

Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition - Tip Sheet

Sylvester Comprehensive Cancer Center — Wed, 13 Nov 2024 13:25:18 EST

Research findings from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University of Miami will be presented at the Annual Meeting & Exposition of the American Society of Hematology in San Diego, Dec. 7-10.

MRI-Guided Radiation Therapy Reduces Long-Term Side Effects for Patients with Prostate Cancer

University of California, Los Angeles (UCLA), Health Sciences — Wed, 13 Nov 2024 12:35:54 EST

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality of life, particularly in bowel and sexual health, compared to conventional CT-guided treatment.

New Study Links Air Pollution with Higher Rates of Head and Neck Cancer

Wayne State University Division of Research — Wed, 13 Nov 2024 11:30:21 EST

A recent study published in the journal Scientific Reports correlates higher levels of pollutant particulate matter to higher occurrences of head and neck aerodigestive cancer.

In 10 Seconds, an AI Model Detects Cancerous Brain Tumor Often Missed During Surgery

Michigan Medicine - University of Michigan — Wed, 13 Nov 2024 11:00:00 EST

Researchers have developed an AI powered model that -- in 10 seconds -- can determine during surgery if any part of a cancerous brain tumor that could be removed remains, a study published in Nature suggests. The technology, called FastGlioma, outperformed conventional methods for identifying what remains of a tumor by a wide margin. Researchers say it has the potential to change the field of neurosurgery by immediately improving comprehensive management of patients with diffuse gliomas.

Ochsner Accountable Care Network saves Medicare $30 million; ranks in top 11% for quality and top 3% in access to care

Ochsner Health — Wed, 13 Nov 2024 09:35:47 EST

For the eighth consecutive year, Louisiana's largest accountable care organization has achieved top-ranking results in both clinical performance and healthcare savings.